Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon

Recruiting Early Phase 1 Interventional Study
Macular Edema (ME) Non Infectious Uveitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
University of Baghdad · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this study is to learn if a suprachoroidal triamcinolone injection can treat vision-threatening swelling in the center of the retina (macular edema) caused by non-infectious uveitis, especially in people who did not improve after a standard steroid injection around the eye (sub-Tenon injection). The main questions it aims to answer are: Does vision improve on the eye chart after the …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Non-infectious uveitis complicated with macular edema * Uveitic macular edema of less than four months' duration * Macular edema persisted despite lack of intra-ocular inflammation * No response to posterior sub-Tenon triamcinolone acetonide injections Exclusion Criteria: * …
Contacts

Mohammed Suhail Al-Salam

+964 790 183 6367

mohammedsuhail@uomustansiriyah.edu.iq

CONTACT